Prof. Ciancio, D.D.S., is Distinguished Service Professor and Chairman in the Department of Periodontics and Endodontics and is the Director of the Center for Dental Studies at the State University of New York (SUNY) at Buffalo, in Buffalo, New York. In addition he is Clinical Professor in the Department of Pharmacology at the University and a Consultant for the Veterans Administration Medical Center and the Erie County Medical Center.
Dr. Ciancio received his degree in Dentistry (D.D.S.) from the School of Dentistry of SUNY where he also completed a NIH Research Fellowship in the Department of Physiology and Fellowships in Pharmacology and Periodontology. His postdoctoral work included studies in Biostatistics at the University of North Carolina in Chapel Hill, North Carolina; Periodontology at SUNY; Radio-isotope Techniques at Western New York Nuclear Center; and Clinical Pharmacology at Vanderbilt University.
He has authored or co-authored well over 150 publications pertaining to periodontal disease. Currently, Dr. Ciancio is Editor of the ADA/PDR Guide to Dental Therapeutics as well as Biological Therapies in Dentistry, a bi-monthly newsletter for dental professionals and Consultant for the Journal of Periodontology & Am. Journal of Dentistry.
Dr. Ciancio is an active member of several professional organizations: He is past Vice Chair of the United States Pharmacopeia Convention, Inc., Committee on Revision to Represent Dentistry; Consultant and past co-chair of the Council on Scientific Affairs of the American Dental Association; Past President of the American Academy of Periodontology; Past President of the American Academy of Periodontology Foundation, Past President of the International Academy of Periodontology, and Director of the annual Chautauqua Dental Congress. He is also a member of the International and American Association for Dental Research, and the Federation Dentaire Internationale.
In recognition of his contributions to dental science, Dr. Ciancio has received numerous honors including the Gies Foundation Award in Periodontics, the Clinical Research Award, the Presidential Award, and the Gold Medal Award presented by The American Academy of Periodontology, Jarvie-Burkhart Award presented by the Dental Society of the State of New York (DSSNY); and Distinguished Service Award by the United States Pharmacopeia, the Hirschfeld Award in Periodontics from the Northeastern Society of Periodontists . the Distinguished Scientist Award in Pharmacology from the International Association for Dental Research.and most recently, the Norton Ross Award for Excellence in Clincal Research from the American Dental Assn. He is also listed in Who’s Who in Continuing Education as a leading continuing education lecturer. He has presented continuing education courses throughout the United States, Canada, and Europe as well as Brazil, Chile, Japan, Argentina, Singapore, Taiwan, Australia and New Zealand.
"Novartis are delighted to continue to support the Future Health Summit. The event is always high quality from its organisation to its speakers, and is a must attend event for anyone with an interest in improving healthcare and outcomes for patients"Ian Addie, Patient Access Head, Novartis Ireland Ltd
"‘Irish Heart would like to extend our thanks for having our mobile health unit attend the Future Health Summit. The mobile health unit was extremely well received and there was over 130 blood pressure checks taken over the two days,. The event was fantastic."Emma Carter ,Mobile Health Unit Manager ,Irish Heart
"‘I have spoken at and attended this event for the last six years and in a short space of time the Future Health Summit has become an annual meeting place for progressive healthcare leaders who want to drive change and improve healthcare delivery. "Mr. Bill Maher, Chief Executive, Bon Secours Health System
"“This Conference is another one of Ireland’s global contributions. The Future Health Summit is required attendance for all who wish to engage in a stimulating interchange on the future of healthcare – globally and domestically""Michael Dowling , Chief Executive Officer of Northwell Health